Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 201-210
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.201
Table 4 Comparison of main outcomes between enhanced recovery after surgery group and control group
Parameter
ERAS group
Control group
P value
Main outcome
Respiratory tract infection21 (18.75%)41 (34.45%)0.007
New/changed X-ray findings48 (42.86%)64 (53.78%)0.114
White blood cell more than 1239 (34.82%)56 (47.06%)0.063
Temperature more than 38 degree centigrade37 (33.04%)54 (45.38%)0.060
Positive sputum bacteria19 (16.96%)31 (26.05%)0.111
Antibiotic therapy22 (19.64%)40 (33.61%)0.018
Secondary results
Preoperative hospitalization time more than 2 d59 (52.68%)65 (54.62%)
Preoperative hospitalization time more than 2 d in patients with respiratory tract infection11 (9.82%)24 (20.17%)0.029
The postoperative length of stay in d9.5 (3-21)11 (4-18)0.028
FEV1/FVC more than 70%86 (76.79%)74 (62.18%)0.022